| scholarly article | Q13442814 |
| P50 | author | David E. Kleiner | Q41449492 |
| Elizabeth J. Phillips | Q91133566 | ||
| P2093 | author name string | Naga Chalasani | |
| Huiman Barnhart | |||
| Jiezhun Gu | |||
| Jay H Hoofnagle | |||
| David Ostrov | |||
| Elizabeth Theresa Cirulli | |||
| Paul Brent Watkins | |||
| Robert John Fontana | |||
| Ryan Schutte | |||
| P2860 | cites work | Structural Basis for T Cell Alloreactivity among Three HLA-B14 and HLA-B27 Antigens | Q27646543 |
| Structural basis of cross-allele presentation by HLA-A*0301 and HLA-A*1101 revealed by two HIV-derived peptide complexes | Q27674409 | ||
| Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire | Q27679355 | ||
| Principal components analysis corrects for stratification in genome-wide association studies | Q27860975 | ||
| Features and development of Coot | Q27861079 | ||
| SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules | Q28090714 | ||
| High resolution HLA-DRB1 identification of a Caucasian population | Q28236763 | ||
| AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility | Q29547658 | ||
| Protein structure homology modeling using SWISS-MODEL workspace. | Q30374281 | ||
| Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database | Q30852962 | ||
| Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset | Q34848118 | ||
| Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles | Q35085772 | ||
| Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality | Q35166739 | ||
| Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations | Q35254140 | ||
| Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study | Q35656015 | ||
| A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs | Q36053665 | ||
| Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury | Q36668300 | ||
| Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct | Q36799781 | ||
| Risk of oral antifungal agent-induced liver injury in Taiwanese | Q37492058 | ||
| Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations | Q37624916 | ||
| Systematic review of severe acute liver injury caused by terbinafine | Q38225439 | ||
| High-resolution HLA A∼B∼DRB1 haplotype frequencies from the Ezer Mizion Bone Marrow Donor Registry in Israel | Q38819320 | ||
| Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study | Q39043874 | ||
| Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury | Q39677764 | ||
| Terbinafine hepatotoxicity: case report and review of the literature | Q41727916 | ||
| Outpatient systemic antimycotic and antifungal use in Europe: new outcome measure provides new insight | Q42249188 | ||
| Terbinafine-induced prolonged cholestasis with reduction of interlobular bile ducts | Q42548382 | ||
| Terbinafine-induced hepatic failure requiring liver transplantation | Q42607592 | ||
| Identification of a reactive metabolite of terbinafine: insights into terbinafine-induced hepatotoxicity | Q43547753 | ||
| High-resolution HLA haplotype frequencies of stem cell donors in Germany with foreign parentage: how can they be used to improve unrelated donor searches? | Q43665880 | ||
| Terbinafine hepatotoxicity resulting in chronic biliary ductopenia and portal fibrosis | Q44038477 | ||
| Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry. | Q51193836 | ||
| Genome-Wide Association Study Identifies Variants Associated With Autoimmune Hepatitis Type 1 | Q56968434 | ||
| Estimation of high-resolution HLA-A, -B, -C, -DRB1 allele and haplotype frequencies based on 8862 German stem cell donors and implications for strategic donor registry planning | Q84408577 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | terbinafine | Q415259 |
| P304 | page(s) | 1317-1325 | |
| P577 | publication date | 2018-08-21 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine | |
| P478 | volume | 69 |
| Q92403226 | Comparison of Different Liver Test Thresholds for Drug-Induced Liver Injury: Updated RUCAM versus Other Methods |
| Q57807859 | Drug-Induced Liver Injury: Highlights of the Recent Literature |
| Q64889734 | Identifying the Antiproliferative Effect of Astragalus Polysaccharides on Breast Cancer: Coupling Network Pharmacology With Targetable Screening From the Cancer Genome Atlas. |
Search more.